Targeted therapies: Remembrance of things past - Discontinuation of second-generation TKI therapy for CML

Timothy Hughes, David Ross

Research output: Contribution to journal › Article › peer-review

6 Citations (Scopus)

Original language	English
Pages (from-to)	201-202
Number of pages	2
Journal	Nature Reviews. Clinical Oncology
Volume	14
Issue number	4
DOIs	https://doi.org/10.1038/nrclinonc.2017.11
Publication status	Published - 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{22344898b01c4ec0be78fb47a52a026d,

title = "Targeted therapies: Remembrance of things past - Discontinuation of second-generation TKI therapy for CML",

author = "Timothy Hughes and David Ross",

year = "2017",

doi = "10.1038/nrclinonc.2017.11",

language = "English",

volume = "14",

pages = "201--202",

journal = "Nature Reviews. Clinical Oncology",

issn = "1759-4774",

publisher = "Nature Publishing Group",

number = "4",

}

TY - JOUR

T1 - Targeted therapies: Remembrance of things past - Discontinuation of second-generation TKI therapy for CML

AU - Hughes, Timothy

AU - Ross, David

PY - 2017

Y1 - 2017

UR - http://www.scopus.com/inward/record.url?scp=85011887038&partnerID=8YFLogxK

U2 - 10.1038/nrclinonc.2017.11

DO - 10.1038/nrclinonc.2017.11

M3 - Article

SN - 1759-4774

VL - 14

SP - 201

EP - 202

JO - Nature Reviews. Clinical Oncology

JF - Nature Reviews. Clinical Oncology

IS - 4

ER -